Product Images Eliquis
View Photos of Packaging, Labels & Appearance
- Bottle Label 5 mg - 71610 0662 09
- Aphena Pharma Solutions - TN - Aphena
- Apixaban Chemical Structure - apixaban struct
- ARISTOTLE Forest Plot - eliquis clin forest fig5
- ARISTOTLE Major Bleeding Forest Plot - eliquis forest fig1
- ARISTOTLE Kaplan-Meier Curve - eliquis km fig4
- Effect of Coadministered Drugs on Pharmacokinetics of Apixaban - eliquis pkplot drugs fig2
- O:\E-Submissions\PBO\PRODUCTS\Eliquis 202155\08. PAS ESRD Dosing\01. Orig Submission\Source\eliquis-pkplot-pop-fig3.jpg - eliquis pkplot pop fig3
Product Label Images
The following 8 images provide visual information about the product associated with Eliquis NDC 71610-662 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 5 mg - 71610 0662 09
Apixaban (Eliquis) is a prescription medication available in the form of tablets with a dosage of 5mg per tablet. The package size consists of 9000 tablets. The drug code (DC#) for this medication is 71610-066209, and there is additional text that is not readable.*
Aphena Pharma Solutions - TN - Aphena
Apixaban Chemical Structure - apixaban struct
ARISTOTLE Forest Plot - eliquis clin forest fig5
ARISTOTLE Major Bleeding Forest Plot - eliquis forest fig1
The given text is a table of various subgroups of patients and their corresponding results for apixaban and warfarin in terms of hazard ratio, number of events, number of patients, and percentage per year. The subgroups include patients with different ages, weights, prior stroke or TIA, diabetes status, geographic region, and other characteristics. The table also shows the reliability of apixaban compared to warfarin for each subgroup.*
ARISTOTLE Kaplan-Meier Curve - eliquis km fig4
Effect of Coadministered Drugs on Pharmacokinetics of Apixaban - eliquis pkplot drugs fig2
This appears to be a table or chart displaying the results of a study on drug interactions. The drugs involved are inhibitors or inducers of P-gp and Strong CYP3A4. The table displays fold change and 90% confidence interval data for the interacting drug's PK (pharmacokinetics) when combined with each of the listed drugs. The results are presented in terms of AUC (area under the curve). The drugs listed include ketoconazole, glarithromycin, diltiazem, naproxen, and rifampin.*
O:\E-Submissions\PBO\PRODUCTS\Eliquis 202155\08. PAS ESRD Dosing\01. Orig Submission\Source\eliquis-pkplot-pop-fig3.jpg - eliquis pkplot pop fig3
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
